Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Platelet-lysate as an autologous alternative for fetal bovine serum in cardiovascular tissue engineering.

Tissue engineering. Part A - 1 Apr 2010

Riem Vis Paul W, Bouten Carlijn V C, Sluijter Joost P G, Pasterkamp Gerard, van Herwerden Lex A, Kluin Jolanda

Abstract excerpt

There is an ongoing search for alternative tissue culture sera to engineer autologous tissues, since use of fetal bovine serum (FBS) is limited under Good Tissue Practice guidelines. We compared FBS with human platelet-lysate (PL) in media for in vitro cell culture. A threefold increase in duplic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Platelets
Share to Cardiovascular System
Share to Collagen Type III

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fetal Blood

Share to Hemolysis

Share to Myocytes, Smooth Muscle

Share to Tissue Engineering

Source

Identifiers

PMID: 19908968
DOI: 10.1089/ten.TEA.2009.0331

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19908968-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Platelet-lysate as an autologous alternative for fetal bovine serum in cardiovascular tissue engineering.PMID 19908968Read ↗

Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene TherapySemantic proximity Read ↗

Human platelet lysate drives clinically compliant generation of vascular mural cells from human pluripotent stem cellsSemantic proximity Read ↗

Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cellsSemantic proximity Read ↗

A proprietary GMP human platelet lysate for the expansion of dermal fibroblasts for clinical applicationsSemantic proximity Read ↗

Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene TherapySemantic proximity Read ↗

Phenotypic study of human gingival fibroblasts in a medium enriched with platelet lysate.Semantic proximity Read ↗

Comparative Characterization of Leukocyte-Rich Platelet-Rich Plasma (L-PRP) and Injectable Platelet-Rich Fibrin (i-PRF): A Laboratory StudySemantic proximity Read ↗

Scaffold and Cell-Based Tissue Engineering Approaches as Alternative Therapy for Blood Vessel DiseaseSemantic proximity Read ↗

Application of human platelet lysate in chondrocyte expansion promotes chondrogenic phenotype and slows senescence progression via BMP-TAK1-p38 pathway.Semantic proximity Read ↗

Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia.Semantic proximity Read ↗

Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cellsSemantic proximity Read ↗

Progenitor Cells Activated by Platelet Lysate in Human Articular Cartilage as a Tool for Future Cartilage Engineering and Reparative Strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.